KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,177,192 | +3.4% | 48,360 | +32.6% | 0.05% | +6.7% |
| Q2 2023 | $7,910,037 | +14.7% | 36,477 | -3.9% | 0.04% | -4.3% |
| Q1 2023 | $6,894,146 | -14.5% | 37,955 | -7.5% | 0.05% | -30.9% |
| Q4 2022 | $8,066,718 | +28.9% | 41,052 | +47.5% | 0.07% | +1.5% |
| Q3 2022 | $6,259,000 | +31.7% | 27,826 | -25.9% | 0.07% | +52.3% |
| Q2 2022 | $4,751,000 | -27.9% | 37,558 | -27.7% | 0.04% | +12.8% |
| Q1 2022 | $6,590,000 | +23.9% | 51,974 | +28.0% | 0.04% | +39.3% |
| Q4 2021 | $5,319,000 | +66.2% | 40,603 | +55.2% | 0.03% | +27.3% |
| Q3 2021 | $3,201,000 | +46.4% | 26,170 | +36.4% | 0.02% | +57.1% |
| Q2 2021 | $2,187,000 | -34.8% | 19,184 | -31.2% | 0.01% | -39.1% |
| Q1 2021 | $3,354,000 | +369.1% | 27,894 | +296.5% | 0.02% | +228.6% |
| Q4 2020 | $715,000 | -54.5% | 7,035 | -65.4% | 0.01% | -63.2% |
| Q3 2020 | $1,571,000 | +66.2% | 20,319 | +139.6% | 0.02% | +46.2% |
| Q2 2020 | $945,000 | – | 8,482 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |